
Quanterix Corporation QTRX
$ 6.36
-1.55%
Quarterly report 2025-Q3
added 11-10-2025
Quanterix Corporation Total Liabilities 2011-2025 | QTRX
Annual Total Liabilities Quanterix Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 78.1 M | 75.3 M | 60.6 M | 64.9 M | 41.3 M | 26.5 M | 25.9 M | 23.6 M | 22.5 M | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 78.1 M | 22.5 M | 46.5 M |
Quarterly Total Liabilities Quanterix Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 130 M | 83.2 M | 80.1 M | 76.5 M | - | 74.5 M | 70.3 M | 78.1 M | 73.9 M | 70 M | 75.3 M | 73.9 M | - | - | 60.6 M | 55.3 M | 62 M | 61.2 M | 64.9 M | 64.9 M | 64.9 M | 64.9 M | 41.3 M | 41.3 M | 41.3 M | 41.3 M | 26.5 M | 26.5 M | 26.5 M | 26.5 M | 25.9 M | 25.9 M | 25.9 M | 25.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 130 M | 25.9 M | 56.7 M |
Total Liabilities of other stocks in the Medical devices industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Abiomed
ABMD
|
165 M | - | - | $ 17.2 B | ||
|
Acutus Medical
AFIB
|
54.8 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B | ||
|
Cognyte Software Ltd.
CGNT
|
281 M | $ 9.33 | 0.24 % | $ 670 M | ||
|
Apyx Medical Corporation
APYX
|
52.3 M | $ 3.41 | -0.8 % | $ 118 M | ||
|
Boston Scientific Corporation
BSX
|
16.7 B | $ 96.27 | 0.22 % | $ 142 B | ||
|
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | ||
|
Bio-Rad Laboratories
BIO
|
2.79 B | $ 305.0 | 0.37 % | $ 8.61 B | ||
|
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M | ||
|
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
73.2 M | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
518 M | - | -10.19 % | $ 1.99 M | ||
|
BioSig Technologies
BSGM
|
2.26 M | - | 37.08 % | $ 85.7 M | ||
|
Electromed
ELMD
|
10.6 M | $ 28.57 | 0.23 % | $ 242 M | ||
|
Bruker Corporation
BRKR
|
3.99 B | $ 48.1 | 0.19 % | $ 7.17 K | ||
|
Abbott Laboratories
ABT
|
36.6 B | $ 125.15 | 0.25 % | $ 218 B | ||
|
Eargo
EAR
|
31.2 M | - | - | $ 10.2 M | ||
|
EDAP TMS S.A.
EDAP
|
45.2 M | $ 3.29 | -3.24 % | $ 123 M | ||
|
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | ||
|
InMode Ltd.
INMD
|
81.9 M | $ 14.78 | 1.09 % | $ 1.17 B | ||
|
IRIDEX Corporation
IRIX
|
24.9 M | $ 1.2 | -2.44 % | $ 19.4 M | ||
|
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | ||
|
IRadimed Corporation
IRMD
|
11.5 M | $ 98.44 | 1.02 % | $ 1.25 B | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
14 M | - | - | $ 111 M | ||
|
LivaNova PLC
LIVN
|
1.19 B | $ 63.06 | 0.3 % | $ 3.42 B | ||
|
Dynatronics Corporation
DYNT
|
12.2 M | - | 14.99 % | $ 929 K | ||
|
LENSAR
LNSR
|
47.7 M | $ 12.05 | 0.87 % | $ 139 M | ||
|
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | ||
|
Second Sight Medical Products
EYES
|
24 M | - | -0.97 % | $ 54.4 M | ||
|
Align Technology
ALGN
|
2.36 B | $ 158.4 | 0.02 % | $ 11.9 B | ||
|
NanoVibronix
NAOV
|
3 M | - | - | $ 1.08 M | ||
|
Accuray Incorporated
ARAY
|
389 M | $ 0.81 | -2.17 % | $ 83.2 M | ||
|
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
13.8 M | $ 13.77 | -1.78 % | $ 372 M | ||
|
FONAR Corporation
FONR
|
53.1 M | $ 14.52 | 0.48 % | $ 95.2 M | ||
|
AxoGen
AXGN
|
99.8 M | $ 32.77 | -0.09 % | $ 1.45 B | ||
|
Orthofix Medical
OFIX
|
390 M | $ 15.35 | 0.71 % | $ 585 M | ||
|
Axonics Modulation Technologies
AXNX
|
89.2 M | - | - | $ 3.31 B | ||
|
GBS
GBS
|
5.44 M | - | -0.57 % | $ 7.12 M | ||
|
CONMED Corporation
CNMD
|
1.34 B | $ 41.17 | 0.91 % | $ 1.27 B | ||
|
OrthoPediatrics Corp.
KIDS
|
119 M | $ 17.45 | 0.66 % | $ 403 M | ||
|
Globus Medical
GMED
|
1.07 B | $ 88.84 | 0.49 % | $ 12.1 B | ||
|
Profound Medical Corp.
PROF
|
12.7 M | $ 7.07 | -4.07 % | $ 180 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
2.49 B | $ 12.74 | 0.95 % | $ 981 M |